Relmada Therapeutics Announces Publication of REL1017 Phase 1 Studies Results - PRNewswire

Submitted by Anonymous (not verified) on Tue, 04/16/2019 - 12:00

Relmada Therapeutics Announces Publication of REL1017 Phase 1 Studies Results  PRNewswireNEW YORK, April 16, 2019 /PRNewswire/ -- Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment ...